{"name":"SOTIO Biotech a.s.","slug":"sotio-biotech-a-s","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOS1d5X2ZDZnQ4dUxnSGdKN0lWTjdHX2JzWWdKMk1vSmczWER5XzVHM0VJX2dpVFBEUk1aYldlQkVwSlZCMHl5UUlUQU15U1ZObUtvLW5JNWVLN1VBZEZtNVB6NWZNQU9yVk5obnpPN3dsQlJMcmItaHFoM29pSVhaeFpSbEFyZjdwSUt2OTNlcHY1eXBxaHFxTFZqMjhfMkktUVhweFZpWktGWW9tclBmT0ZacFhKODlVcVMtd3VZQ09LSVFjM2FfcTlreWlHYjdac1p5czJQRC0zbzZ6Ty1aRW9MWEpHSzhBNlBvZks0d3BQbmV4WFE?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQkp2Q2YxcFhMX3ZUaS1GMDlOY0REWWcxSGl3ZVJVVkFjYk0yQmhVN1ktWE5TOXFWYi1wTF8zd09uZDBiMkk1SEZxaDVCakplWlpBZWVZaFh1ZFBkeUZrbklUeWJuLWlDNi1FWmo4dG1NSG9uY1Q5RnNHckpjWUxzSkZ6M2loeDBPSG5DcFBJTzhtb3hfNDlPUmRIcjh4ejNNeGdXOVhQcmNsUQ?oc=5","date":"2026-03-10","type":"pipeline","source":"Drug Target Review","summary":"World ADC 2026: where antibody-drug conjugates are heading - Drug Target Review","headline":"World ADC 2026: where antibody-drug conjugates are heading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9qV3BOeVNudVZOWkZDSFhWaTM5akRMdTBGbUxzVDc1eE9lOGRSM3Z4eXA4bFQ4a2xZdHF2WTBOdzB4TlNuM09yYlpuNC1rZHhudG5oZFZUSnJvRFplX0Z1NkxtWmR1Q2VDQ19EUHp30gFyQVVfeXFMTWl0M0ZPLUdVSVQ4WWZCelBRbXc4MkFxakJray1QQnpLM1g2bXRYWmZ6NVQ0Y3lYdWRIdS0xaGV3TTRzd1IwQUxka0prQ2FPbnRLYVYzUG1aRUNMM3ZLWS1EaUhLTE5tR3VzOUNuMmMtNEZR?oc=5","date":"2026-02-09","type":"trial","source":"koreabiomed.com","summary":"LigaChem Bio secures ADC milestone as SOTIO advances SOT106 toward clinical trials - koreabiomed.com","headline":"LigaChem Bio secures ADC milestone as SOTIO advances SOT106 toward clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNUZLQkM1bGVIekpucEl4Z04wSVowNXh5MzUwdHdSR3NYanpHV3ZyQ0hqZnd4LUFRaG9RTXNOLXdfdGJhX1FnMnlsY0RrSXVDdTduelJEa2tIVXZ6VHRuMXh2dzJZQ3BwN2p1aWRvb2V2S3l0TXRQakdXZDdtRHZnUGl5ZFZ2YlhTb3BHRHNhcHFlclBmVXIzRHcyeDRuZw?oc=5","date":"2025-11-07","type":"pipeline","source":"Fierce Biotech","summary":"Recursion refreshes leadership with CEO swap—Chutes & Ladders - Fierce Biotech","headline":"Recursion refreshes leadership with CEO swap—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQbTAxcmVMOVBkcjZ6NTZIbXlYR2hKMlJtLWFKTzJQSGNwaFFqdDlpcml3Q2tLeWtVZzdMemRQZ1FyQnI3bHlJNkRzeV94Rks4Wjc4NlhWVE1abUdXUmxBTVlSZHl6aUFPMUZac1ZEWnViQWgta1M4UE1mSS14S3ZMSWhXTXd0alVPdWc?oc=5","date":"2025-11-04","type":"pipeline","source":"The Pharma Letter","summary":"SOTIO promotes Vivi Boura to CMO role - The Pharma Letter","headline":"SOTIO promotes Vivi Boura to CMO role","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxOQnVMZjBIMnRadVZZWkJTZGdNU3E0YkV6blU4ZTZwbEVuV09udVJvZDEzTFRmcjhjb1NhRDctNktxUHA1SmViU0xNYVNZejhOUS1XeFJVR3A2VzQ2MjAweE9EdHJJVzhMV0cxYUM0eF9CV0drVXhwbmQ2bHF2YzE5U2M5V0I5cUhtMXdFM1NjckE1dGhXR21uMzBfeWtaWEtkMkdkZnFZd1NDc3NldFFmVndCUEF3elRtNUJGMUpkLWF0UV9ITHpTOURBVS1KY3ZTN24tMWMzMlEyaGdVUXlLZ2JFRE5wWHhUODVFRGxfQlJTSXVkeTMtclBIbXVSQjJEdGxOSHFYdmxvRmtYUDN5RDdIY1NaRmZhQlpORm1oeXo1alRXbzh6SVUzT25SUlhWN3RXMkJJX1dFS2MyTF8wVjZzVGRqNkU?oc=5","date":"2025-10-23","type":"pipeline","source":"prnewswire.com","summary":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight - prnewswire.com","headline":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Dia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNbURMbHA5QUFwNXRwMlU0UVFQcFc4OENfTXFmMEF0ZDJXd0c2Ri03NUJDNzZKTV93OFBzRHpqb0oxZVNPTnBLNDFUaXViV29UZjc2cjN0RkoxMS1DVXVPaFFzYkQwNnVEVGlJdXNyWTFtVzgwWFFkbVdnajB3cHJvYVgwUG53Zy1lVjYtVEE2T1E?oc=5","date":"2025-10-03","type":"pipeline","source":"Fierce Biotech","summary":"GSK chief steps down in stunning move—Chutes & Ladders - Fierce Biotech","headline":"GSK chief steps down in stunning move—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE02bzJaM3ZiczZiSUtwcjRXTG5zTlFOUHNOSmZHYkFtcDNYQlhGR0U3bGNMR0ZGTGV2TG1UOXFqSWs4YXBwaExQcFZZd09QTkhNd20w?oc=5","date":"2025-03-13","type":"pipeline","source":"FirstWord Pharma","summary":"Sotio, Synaffix share ADC updates, along with ImmunoPrecise Antibodies - FirstWord Pharma","headline":"Sotio, Synaffix share ADC updates, along with ImmunoPrecise Antibodies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOQ2s5N2lDcXNOVkRPbUF2Sy1JN1RiZE9uLTJmVF9uRjRPLWJMc2I0Vy1oRDJkOXNsWHhQOGxnUHNZaVV4OERXYU9SU01pMmlJUDdWUWlIWUxMaXVQVk5GeU1leWlwR2dfT3JRNzBnT1gtYzM1aWdyNGIzdVpzaU1HVkRfbGxjT1V5cFphS0VUUTlsMkViYW5GYXRpVFRFUFc0V3pIQk1yM09wS3ZmRjE5cmZKbDgxZXRaVEFqaE9XaHBxVGVPQngtd1V1WlZCcGpBNzB0TlZJbk45bllTTlpWUXRQT0FzRVlKZnB4REJ1UVU4RUNVSjJKU2VJVDJ1LURja1RBaXZXMW9od2Q2ck1OVw?oc=5","date":"2025-01-09","type":"deal","source":"Business Wire","summary":"SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumor Target - Business Wire","headline":"SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1pdGVReGJ2bk9XenZDN3RITHR0Y2ZBUFc0YXdGaGRJQy1keFBPRWxIZjRrYjB3bUw2VTJuaFJROU1qdTNhNVV1MVNmd3NJX3RiRWlxV2ZCMGpPMHBFaDJtR05B?oc=5","date":"2024-09-03","type":"pipeline","source":"PharmaTimes","summary":"Geoffrey Hodge - PharmaTimes","headline":"Geoffrey Hodge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQTnFBZFpYM1JaaTF4UGtyZmlHQm1rSjVlSWgzOHNob1V6M1hzTGNha0hCMlBRZmdqLWxOZmI5MEJ5Z09HS1l0M1ktajZ1enNzYzBxYmtKMFlQajFBcTRuMVlBM3JFVFZ5My14Nm5vaXFpRWktTW5MSDlkZkRKM05mOExFX0JkVFhGUWZNejF3eXYtSi1Ga0Jr?oc=5","date":"2024-07-17","type":"pipeline","source":"BioWorld News","summary":"Sotio, Biocytogen link up in $325M ADC discovery pact - BioWorld News","headline":"Sotio, Biocytogen link up in $325M ADC discovery pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOcG5CZWpjcFRWdDg5MTZNTUlyUnE1X25jbEVrcnZrX2NRYnBOb3NnczFud251NGkxeVJaUG03QkE2cVZPSlZtMkFnUlRNZHpDeHRUdmd4eHJQNmtRblhNMThmdEVFZjNydHRLVFMxbHJzdlplcXJVR2w3eFZtOXJ1OGRLeUpnaVRmY2hwVElmTFU2c1AyTEVGWnB3Qk1LbEdZMVRvMG0wanVaMWlxam5DbGZZMm4tUmRRQ3oyVkg5Nm1KdGJVbkZPUVpTZWU1enZxT2NYLUJzZEo2RDFIa1cyaVEwTGFnWWZJOUpJSG9DNTBfdnpKZzUtSFlyb19WNWVTR0xNLUdvOGM0V2dpVmUxaUZ3SndOWVFzSDRpRDFmNTFRVE16RFNPZ2NJOVVFalI3T1E?oc=5","date":"2022-06-07","type":"deal","source":"PPF Group","summary":"Heidelberg announced a $1 billion deal with Huadong focused on developing ADCs in Asia - PPF Group","headline":"Heidelberg announced a $1 billion deal with Huadong focused on developing ADCs in Asia","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}